This inventor holds 2 USPTO granted patents. Top assignees: Leukosite, Inc., Millennium Pharmaceuticals Limited. Active years: 2000-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2001
Title: Hitesh N Shroff: Innovator in Peptide-Based Therapeutics
Introduction
Hitesh N Shroff is a notable inventor based in Bedford, MA (US). He has made significant contributions to the field of peptide-based therapeutics, holding 2 patents that focus on innovative methods for inhibiting specific cellular interactions.
Latest Patents
His latest patents include "Inhibitors of MadCAM-1-mediated interactions and methods of use therefor." This invention provides novel compounds comprising peptide sequences that mimic the conserved amino acid motif LDTSL of MAdCAM-1. These compounds have groups bonded to the N- and C-termini. The patent also outlines methods for inhibiting the interaction of a cell bearing a ligand of MAdCAM-1, such as human α4β7, with MAdCAM-1 or a portion thereof, by contacting the cell with a compound of the present invention.
Career Highlights
Throughout his career, Hitesh has worked with prominent companies in the pharmaceutical industry, including Leukosite, Inc. and Millennium Pharmaceuticals Limited. His work has contributed to advancements in therapeutic strategies targeting specific cellular interactions.
Collaborations
Hitesh has collaborated with various professionals in his field, including his coworker Charles F Schwender. These collaborations have further enhanced the development of his innovative ideas and patents.
Conclusion
Hitesh N Shroff is a distinguished inventor whose work in peptide-based therapeutics has led to valuable patents and advancements in the field. His contributions continue to influence the development of innovative treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
